v3.25.4
Interests in associates - Summarized statement of comprehensive income (Details) - EUR (€)
€ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Interests in associates      
Revenue € 19,627,602 € 19,335,909 € 19,453,617
Profit for the period 1,191,267 740,870 732,458
Other comprehensive income (1,466,407) 715,902 (630,011)
Total comprehensive income (275,140) 1,456,772 € 102,447
Vifor Fresenius Medical Care Renal Pharma Ltd.      
Interests in associates      
Revenue 950,888 741,183  
Profit from continuing operations 456,306 290,766  
Profit for the period 456,306 290,766  
Other comprehensive income (3,428) (116,914)  
Total comprehensive income 452,878 173,852  
Dividends received € 137,174 € 92,386